Searched for
LUNG ADENOCARCINOMA
Pope Leo lung cancer raises serious questions about cancer risk for nonsmokers. Here's what researchers are sayingPope Leo had the lower lobe of his right lung removed after doctors identified a suspected cancerous nodule. The surgery confirmed he had a...
What is multiple myeloma? Louis Prevost, Pope Leo’s older brother, also battles cancer; his wife reveals shocking detailsLouis Prevost, brother of Pope Leo XIV, is facing the challenges of multiple myeloma diagnosed back in 2017. Recent health issues have led ...
Pope Leo health: Pope Leo XIV resumes regular diet, celebrates Mass in hospital as doctor shares latest update on lung cancer recoveryPope Leo health: The Vatican said that the pope had celebrated Mass with his secretaries in the afternoon in a special chapel set up for hi...
Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at riskPope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...
Pope Leo XIV, diagnosed with lung cancer, undergoes surgery. What is lung adenocarcinoma? 7 symptoms you should not ignoreAdenocarcinoma is a type of cancer that arises from glandular or secretory cells. Adenocarcinoma is the predominant variant of lung cancer....
- Pope Leo XIV diagnosed with lung cancer after surgery to remove part of right lung
Pope Leo XIV recently had surgery confirming a diagnosis of lung adenocarcinoma, leading to the removal of a lung lobe. The operation was d...
Pope Leo lung cancer: What is adenocarcinoma, is it life threatening? Vatican offers surgery update, health statusPope Leo XIV underwent surgery on Tuesday that confirmed that he has lung cancer, and doctors removed the lower lobe of his right lung, the...
Cipla gets USFDA nod for generic cancer drugCipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable suspension (100...
Zydus Lifesciences inks licensing pact with Zhuhai for cancer drugZydus Lifesciences' subsidiary partners with Zhuhai Beihai Biotech to market Beizray, a cancer drug, in the US. Zhuhai will handle manufact...
New AI Model, Ceograph, can predict cancer outcomes using tissue samplesThe model analyses the spatial arrangement of cells in tissue, mimicking how pathologists read slides.
Alembic Pharma gets USFDA nod to market generic cancer drugDocetaxel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcin...
World Lung Cancer Day: Quit smoking recently? Watch out for discomfort in chest, fatigue & swelling around neckNon-smokers are also susceptible to different types of lung cancer.
Non-smokers get cancer too, insurer can’t stub claim: Gujarat courtThe case involved one Alok Kumar Banerjee from Thaltej, who underwent treatment for adenocarcinoma of the lung from Vedanta Institute of Me...
How lung cancer arises in non-smokers revealedLung cancer is the leading cause of cancer-related deaths worldwide. Environmental risk factors, such as exposure to radon, air pollution, ...
Contrary to popular belief, lung cancer on the rise among young womenThe study examined lung cancer rates in young adults in 40 countries across five continents.
Shilpa Medicare gets USFDA nod for cancer drugShilpa Medicare has received USFDA final approval for its abbreviated new drug application.
World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.
New AI system may be able to identify lung cancer typeThe AI tool was also able to determine whether abnormal versions of 6 genes linked to lung cancer were present in cells.
Panacea Biotec tanks 6% after CARE downgrades firmCurrently, the m-cap of the company stands at Rs 1,508.61 crore.
Glenmark, Particle Sciences to develop generic cancer drugThe partnership will develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers.